Whales Gobble Up 181K LTC in Days as Grayscale ETF Rumors Fuel Buying Frenzy

Big money moves fast when opportunity knocks—and right now, LTC is ringing the dinner bell.

Grayscale's Whisper Campaign

Rumors of a new Litecoin ETF have whales loading up another 181,000 LTC in just days. Because nothing gets institutional money flowing like the prospect of easier exits for early bagholders.

ETF Mania Strikes Again

The crypto world’s obsession with ETF approval continues—because if there’s one thing finance loves, it’s repackaging existing assets into fee-generating products. Grayscale’s potential move signals yet another step toward legitimizing crypto… or just another way to charge management fees on digital silver.

Buy the Rumor, Sell the News—Or Just Keep Hoarding

Whales aren’t waiting for official announcements. They’re front-running the narrative, betting that even ETF speculation can pump prices. Because in crypto, sometimes the hype is just as valuable as the product.

Grayscale files to transform its funds into ETFs

Grayscale is in the process of upgrading its ETP into a full ETF. Currently, the ETP is trading at a discount against the price on crypto markets. 

The ETP is relatively idle, as mainstream interest in LTC remains low. The LTCN shares rallied in late 2024, but are yet to regain their premium. Recently, Grayscale filed an S-3 FORM to transform its previous product. Grayscale holds around 2M LTC in its Trust, which may become the basis for the new ETF. 

Additionally, an anonymous whale wallet loaded up over 36K coins in the past week, becoming the most active buyer. For now, there is no detailed tracking of LTC purchases or special treasury entities. 

LTC has been accumulating into large wallets, with those holding 10,000 to 100K coins controlling around 29% of the supply. Another 26% of the supply is held in wallets with 100K to 1M LTC. The coin has multiple whales with the potential to sway the market, or hold onto their assets to create scarcity. 

MEI Pharma rebrands to Lite Strategy

MEI Pharma is moving along with its Litecoin acquisition strategy, starting with a name change. The pharmaceutical company rebranded itself to Lite Strategy, while retaining some of its pharma activity, Cryptopolitan reported. The MEIPS ticker will also be replaced by LITS. 

The ticker changes, but the asset will remain the same.$MEIP is becoming $LITS. pic.twitter.com/2Oavc0iwTs

— Lite Strategy (@LiteStrategy) September 10, 2025

The former ticker still traded at around $3.11, NEAR the lower range for the past month. The company already rallied after the initial $100M treasury announcement. The current treasury holds 929,548 LTC, acquired at $107.58, with a slight premium following the recent market recovery.

LTC remains one of the widely used assets, attracting users for payments, arbitrage, and mining. The coin expanded its mining rate for the past year, growing by 200% for the past year to 3 PH/s. 

However, the coin lacks the meme potential from previous bull markets, even after its attempts at social media presence. Despite this, LTC remains a solid proposition with a long history and growing scarcity. LTC has already mined over 76M coins, out of the total 84M. 

Get $50 free to trade crypto when you sign up to Bybit now